| Sources | Names Used |
|---|---|
| GDSC1000 | KIN001-102 |
| PharmacoGx | KIN001-102 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLLT11 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.005 |
| mRNA | CCDC122 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.005 |
| mRNA | RXFP1 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.005 |
| mRNA | HIC2 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.005 |
| mRNA | EMP3 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | OR6B1 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.005 |
| mRNA | FBXW11 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.005 |
| mRNA | TMEM5 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.005 |
| mRNA | GZMB | GDSC1000 | pan-cancer | AAC | -0.081 | 0.005 |
| mRNA | CECR6 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.006 |
